市場調査レポート

商品コード

医薬品有効成分の世界市場 2025-2029年

Global Active Pharmaceutical Ingredients Market 2025-2029

出版日: 2024年12月17日
発行: TechNavio
ページ情報: 英文 200 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 371,725円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 594,760円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.69円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

医薬品有効成分市場 2025-2029年

医薬品有効成分市場は2024-2029年に976億米ドル、予測期間中のCAGRは7.1%で成長すると予測されます。当レポートでは、医薬品有効成分市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。新興国市場におけるAPI製造シナリオの進化、タイプII医薬品マスターファイル（DMF）の増加、コアコンピタンスに集中するニーズの高まりなどが市場を牽引しています。

市場範囲
基準年	2025
終了年	2029
予測期間	2025-2029
成長モメンタム	加速
前年比2025年	6.5%
CAGR	7.1%
増分額	976億米ドル

本調査では、今後数年間の医薬品有効成分市場成長を牽引する主な要因の一つとして、API製造におけるパラダイムシフトを挙げています。また、特許行使の増加や老年人口の増加が市場の大きな需要につながると思われます。

地域別セグメンテーション
地域別：比較
アジア：市場規模と予測 2024-2029
北米：市場規模と予測 2024-2029
欧州：市場規模と予測 2024-2029
世界のその他の地域：市場規模と予測 2024-2029
中国：市場規模と予測 2024-2029
インド：市場規模と予測 2024-2029
米国：市場規模と予測 2024-2029
日本：市場規模と予測 2024-2029
ドイツ：市場規模と予測 2024-2029
英国：市場規模と予測 2024-2029
カナダ：市場規模と予測 2024-2029
フランス：市場規模と予測 2024-2029
ブラジル：市場規模と予測 2024-2029
イタリア：市場規模と予測 2024-2029
市場機会：地域情勢別

第12章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第13章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第14章競合分析

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
AbbVie Inc.
Amneal Pharmaceuticals Inc.
Aurobindo Pharma Ltd.
Cadila Pharmaceuticals Ltd.
Cipla Inc.
Dr Reddys Laboratories Ltd.
GlaxoSmithKline Plc
Koninklijke DSM NV
Lupin Ltd.
Novartis AG
Pfizer Inc.
Sanofi SA
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

第15章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Manufacturing Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2024 and 2029
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value chain analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Historic Market Size - Data Table on Global Active Pharmaceutical Ingredients Market 2019 - 2023 ($ billion)
Exhibits25: Historic Market Size - Manufacturing Type Segment 2019 - 2023 ($ billion)
Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ billion)
Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits29: Five forces analysis - Comparison between 2024 and 2029
Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits35: Chart on Market condition - Five forces 2024 and 2029
Exhibits36: Chart on Manufacturing Type - Market share 2024-2029 (%)
Exhibits37: Data Table on Manufacturing Type - Market share 2024-2029 (%)
Exhibits38: Chart on Comparison by Manufacturing Type
Exhibits39: Data Table on Comparison by Manufacturing Type
Exhibits40: Chart on Captive APIs - Market size and forecast 2024-2029 ($ billion)
Exhibits41: Data Table on Captive APIs - Market size and forecast 2024-2029 ($ billion)
Exhibits42: Chart on Captive APIs - Year-over-year growth 2024-2029 (%)
Exhibits43: Data Table on Captive APIs - Year-over-year growth 2024-2029 (%)
Exhibits44: Chart on Contract APIs - Market size and forecast 2024-2029 ($ billion)
Exhibits45: Data Table on Contract APIs - Market size and forecast 2024-2029 ($ billion)
Exhibits46: Chart on Contract APIs - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Contract APIs - Year-over-year growth 2024-2029 (%)
Exhibits48: Market opportunity by Manufacturing Type ($ billion)
Exhibits49: Data Table on Market opportunity by Manufacturing Type ($ billion)
Exhibits50: Chart on Type - Market share 2024-2029 (%)
Exhibits51: Data Table on Type - Market share 2024-2029 (%)
Exhibits52: Chart on Comparison by Type
Exhibits53: Data Table on Comparison by Type
Exhibits54: Chart on Innovative APIs - Market size and forecast 2024-2029 ($ billion)
Exhibits55: Data Table on Innovative APIs - Market size and forecast 2024-2029 ($ billion)
Exhibits56: Chart on Innovative APIs - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Innovative APIs - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Generic APIs - Market size and forecast 2024-2029 ($ billion)
Exhibits59: Data Table on Generic APIs - Market size and forecast 2024-2029 ($ billion)
Exhibits60: Chart on Generic APIs - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Generic APIs - Year-over-year growth 2024-2029 (%)
Exhibits62: Market opportunity by Type ($ billion)
Exhibits63: Data Table on Market opportunity by Type ($ billion)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits70: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits71: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits73: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits74: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits75: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits77: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits78: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits79: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits85: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits86: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits87: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits88: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits89: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits90: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits91: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits94: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits95: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits98: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits99: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits102: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits103: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits110: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits111: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits114: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits115: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits118: Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits119: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits122: Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits123: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits125: Market opportunity By Geographical Landscape ($ billion)
Exhibits126: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits127: Impact of drivers and challenges in 2024 and 2029
Exhibits128: Overview on criticality of inputs and factors of differentiation
Exhibits129: Overview on factors of disruption
Exhibits130: Impact of key risks on business
Exhibits131: Companies covered
Exhibits132: Company ranking index
Exhibits133: Matrix on companies position and classification
Exhibits134: AbbVie Inc. - Overview
Exhibits135: AbbVie Inc. - Product / Service
Exhibits136: AbbVie Inc. - Key news
Exhibits137: AbbVie Inc. - Key offerings
Exhibits138: SWOT
Exhibits139: Amneal Pharmaceuticals Inc. - Overview
Exhibits140: Amneal Pharmaceuticals Inc. - Business segments
Exhibits141: Amneal Pharmaceuticals Inc. - Key news
Exhibits142: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits143: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits144: SWOT
Exhibits145: Aurobindo Pharma Ltd. - Overview
Exhibits146: Aurobindo Pharma Ltd. - Product / Service
Exhibits147: Aurobindo Pharma Ltd. - Key offerings
Exhibits148: SWOT
Exhibits149: Cadila Pharmaceuticals Ltd. - Overview
Exhibits150: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits151: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits152: SWOT
Exhibits153: Cipla Inc. - Overview
Exhibits154: Cipla Inc. - Business segments
Exhibits155: Cipla Inc. - Key news
Exhibits156: Cipla Inc. - Key offerings
Exhibits157: Cipla Inc. - Segment focus
Exhibits158: SWOT
Exhibits159: Dr Reddys Laboratories Ltd. - Overview
Exhibits160: Dr Reddys Laboratories Ltd. - Business segments
Exhibits161: Dr Reddys Laboratories Ltd. - Key news
Exhibits162: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits163: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits164: SWOT
Exhibits165: GlaxoSmithKline Plc - Overview
Exhibits166: GlaxoSmithKline Plc - Business segments
Exhibits167: GlaxoSmithKline Plc - Key news
Exhibits168: GlaxoSmithKline Plc - Key offerings
Exhibits169: GlaxoSmithKline Plc - Segment focus
Exhibits170: SWOT
Exhibits171: Koninklijke DSM NV - Overview
Exhibits172: Koninklijke DSM NV - Business segments
Exhibits173: Koninklijke DSM NV - Key news
Exhibits174: Koninklijke DSM NV - Key offerings
Exhibits175: Koninklijke DSM NV - Segment focus
Exhibits176: SWOT
Exhibits177: Lupin Ltd. - Overview
Exhibits178: Lupin Ltd. - Business segments
Exhibits179: Lupin Ltd. - Key news
Exhibits180: Lupin Ltd. - Key offerings
Exhibits181: Lupin Ltd. - Segment focus
Exhibits182: SWOT
Exhibits183: Novartis AG - Overview
Exhibits184: Novartis AG - Business segments
Exhibits185: Novartis AG - Key news
Exhibits186: Novartis AG - Key offerings
Exhibits187: Novartis AG - Segment focus
Exhibits188: SWOT
Exhibits189: Pfizer Inc. - Overview
Exhibits190: Pfizer Inc. - Product / Service
Exhibits191: Pfizer Inc. - Key news
Exhibits192: Pfizer Inc. - Key offerings
Exhibits193: SWOT
Exhibits194: Sanofi SA - Overview
Exhibits195: Sanofi SA - Business segments
Exhibits196: Sanofi SA - Key news
Exhibits197: Sanofi SA - Key offerings
Exhibits198: Sanofi SA - Segment focus
Exhibits199: SWOT
Exhibits200: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits201: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits202: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits203: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits204: SWOT
Exhibits205: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits206: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits207: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits208: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits209: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits210: SWOT
Exhibits211: Viatris Inc. - Overview
Exhibits212: Viatris Inc. - Business segments
Exhibits213: Viatris Inc. - Key news
Exhibits214: Viatris Inc. - Key offerings
Exhibits215: Viatris Inc. - Segment focus
Exhibits216: SWOT
Exhibits217: Inclusions checklist
Exhibits218: Exclusions checklist
Exhibits219: Currency conversion rates for US$
Exhibits220: Research methodology
Exhibits221: Information sources
Exhibits222: Data validation
Exhibits223: Validation techniques employed for market sizing
Exhibits224: Data synthesis
Exhibits225: 360 degree market analysis
Exhibits226: List of abbreviations

Product Code: IRTNTR40608

Active Pharmaceutical Ingredients Market 2025-2029

The active pharmaceutical ingredients market is forecasted to grow by USD 97.6 bn during 2024-2029, accelerating at a CAGR of 7.1% during the forecast period. The report on the active pharmaceutical ingredients market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by evolving api manufacturing scenario in developing scenario, increasing number of type ii drug master files (DMF), and growing need to focus on core competencies.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.5%
CAGR	7.1%
Incremental Value	$97.6 bn

Technavio's active pharmaceutical ingredients market is segmented as below:

By Manufacturing Type

Captive APIs
Contract APIs

By Type

Innovative APIs
Generic APIs

By Geographical Landscape

Asia
North America
Europe
Rest of World (ROW)

This study identifies the paradigm shift in api manufacturing as one of the prime reasons driving the active pharmaceutical ingredients market growth during the next few years. Also, increasing patent exercises and increasing geriatric population will lead to sizable demand in the market.

The report on the active pharmaceutical ingredients market covers the following areas:

Active Pharmaceutical Ingredients Market sizing
Active Pharmaceutical Ingredients Market forecast
Active Pharmaceutical Ingredients Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading active pharmaceutical ingredients market vendors that include AbbVie Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cambrex Corp., Cipla Inc., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Indena S.p.A., INTERNATIONAL CHEMICAL INVESTORS S.E., Koninklijke DSM NV, Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Viatris Inc.. Also, the active pharmaceutical ingredients market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Manufacturing Type
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Active Pharmaceutical Ingredients Market 2019 - 2023
- Historic Market Size - Data Table on Global Active Pharmaceutical Ingredients Market 2019 - 2023 ($ billion)
5.2 Manufacturing Type segment analysis 2019 - 2023
- Historic Market Size - Manufacturing Type Segment 2019 - 2023 ($ billion)
5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

6.1 Impact of AI on Global Active Pharmaceutical Ingredients Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Manufacturing Type

8.1 Market segments
- Chart on Manufacturing Type - Market share 2024-2029 (%)
- Data Table on Manufacturing Type - Market share 2024-2029 (%)
8.2 Comparison by Manufacturing Type
- Chart on Comparison by Manufacturing Type
- Data Table on Comparison by Manufacturing Type
8.3 Captive APIs - Market size and forecast 2024-2029
- Chart on Captive APIs - Market size and forecast 2024-2029 ($ billion)
- Data Table on Captive APIs - Market size and forecast 2024-2029 ($ billion)
- Chart on Captive APIs - Year-over-year growth 2024-2029 (%)
- Data Table on Captive APIs - Year-over-year growth 2024-2029 (%)
8.4 Contract APIs - Market size and forecast 2024-2029
- Chart on Contract APIs - Market size and forecast 2024-2029 ($ billion)
- Data Table on Contract APIs - Market size and forecast 2024-2029 ($ billion)
- Chart on Contract APIs - Year-over-year growth 2024-2029 (%)
- Data Table on Contract APIs - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Manufacturing Type
- Market opportunity by Manufacturing Type ($ billion)
- Data Table on Market opportunity by Manufacturing Type ($ billion)

9 Market Segmentation by Type

9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
9.3 Innovative APIs - Market size and forecast 2024-2029
- Chart on Innovative APIs - Market size and forecast 2024-2029 ($ billion)
- Data Table on Innovative APIs - Market size and forecast 2024-2029 ($ billion)
- Chart on Innovative APIs - Year-over-year growth 2024-2029 (%)
- Data Table on Innovative APIs - Year-over-year growth 2024-2029 (%)
9.4 Generic APIs - Market size and forecast 2024-2029
- Chart on Generic APIs - Market size and forecast 2024-2029 ($ billion)
- Data Table on Generic APIs - Market size and forecast 2024-2029 ($ billion)
- Chart on Generic APIs - Year-over-year growth 2024-2029 (%)
- Data Table on Generic APIs - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.4 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
11.5 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
11.8 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
11.9 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
11.10 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.11 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
11.13 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.14 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
11.15 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
11.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
14.5 Amneal Pharmaceuticals Inc.
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key news
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
14.6 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
14.7 Cadila Pharmaceuticals Ltd.
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- SWOT
14.8 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
14.9 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
14.10 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
14.11 Koninklijke DSM NV
- Koninklijke DSM NV - Overview
- Koninklijke DSM NV - Business segments
- Koninklijke DSM NV - Key news
- Koninklijke DSM NV - Key offerings
- Koninklijke DSM NV - Segment focus
- SWOT
14.12 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
14.13 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
14.14 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
14.15 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
14.16 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
14.17 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
14.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations

医薬品有効成分の世界市場 2025-2029年

Global Active Pharmaceutical Ingredients Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio別分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：製造タイプ別

第9章市場セグメンテーション：タイプ別

第10章顧客情勢

第11章地域別情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Manufacturing Type

9 Market Segmentation by Type

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

医薬品有効成分の世界市場 2025-2029年

Global Active Pharmaceutical Ingredients Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio別分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：製造タイプ別

第9章 市場セグメンテーション：タイプ別

第10章 顧客情勢

第11章 地域別情勢

第12章 促進要因・課題・機会・抑制要因

第13章 競合情勢

第14章 競合分析

第15章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Manufacturing Type

9 Market Segmentation by Type

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：製造タイプ別

第9章市場セグメンテーション：タイプ別

第10章顧客情勢

第11章地域別情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録